Samsung Medical Center: clinical-trial pipeline
Samsung Medical Center is the sponsor of 1,005 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 154 are not yet finished and 9 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials154
Phase 2/3 and 365
Countries8
New in 90 days9
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 651 |
| Phase 2 | 185 |
| Phase 4 | 68 |
| Phase 3 | 59 |
| Phase 1 | 19 |
| Phase 1/2 | 15 |
| Phase 2/3 | 6 |
| Early phase 1 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 488 |
| Unknown | 316 |
| Recruiting | 103 |
| Active, not recruiting | 29 |
| Terminated | 23 |
| Not yet recruiting | 22 |
| Withdrawn or not authorised | 22 |
| Suspended or halted | 2 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 432 |
| Cardiovascular | 200 |
| Neurology | 85 |
| Nephrology and urology | 79 |
| Gastroenterology and liver | 66 |
| Rare and genetic diseases | 48 |
| Metabolic and endocrine (diabetes, obesity) | 40 |
| Respiratory | 30 |
| Ophthalmology | 25 |
| Immunology and rheumatology | 22 |
| Psychiatry and mental health | 20 |
| Women's health and obstetrics | 20 |
Countries
| Country | Trials |
|---|---|
| South Korea | 921 |
| China | 4 |
| United States | 2 |
| Indonesia | 1 |
| Malaysia | 1 |
| Singapore | 1 |
| Thailand | 1 |
| Taiwan | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-21 | New trial posted | PULSAR Radiotherapy Combined With Immunotherapy for High-Risk Advanced Liver Cancer |
| 2026-10-09 | New trial posted | Effect of an AI Agent on Caregiver Communication Experience in the Pediatric Emergency De… |
| 2026-10-06 | New trial posted | Feasibility Study of an Interactive Remote Supervising Platform for Critical Care: A Rand… |
| 2026-10-01 | New trial posted | Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism |
| 2026-09-17 | New trial posted | Feasibility of Vision-Language Models for Detecting Physical Assistance as an Observable… |
| 2026-09-15 | New trial posted | Opiranserin Injections PCA Regimens for Postoperative Pain |
| 2026-09-08 | New trial posted | Wearable Eye Tracking During Bimanual Tasks in Children With Cerebral Palsy |
| 2026-09-03 | New trial posted | Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB Omission |
| 2026-08-31 | New trial posted | 3D Transthoracic Echocardiographic Evaluation on Tricuspid Regurgitation Progression and… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06684678 | Individualized Automatic Coaching Message for Glycemic Management and Depressive Symptom | Not applicable | Not yet recruiting | South Korea |
| NCT04899479 | Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myo… | Phase 4 | Recruiting | South Korea |
| NCT03578185 | Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy | Not applicable | Recruiting | South Korea |
| NCT06552559 | Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma | Phase 1/2 | Recruiting | South Korea |
| NCT04665687 | Clinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma Patients | Not applicable | Recruiting | South Korea |
| NCT07637591 | Evaluation of a Generative AI-Based Voice Documentation System for Patient-Clinician Communication in the Eme… | Not applicable | Active, not recruiting | South Korea |
| NCT07115173 | Clinical Trial to Evaluate the Efficacy of Probit-Based Triple Therapy for Helicobacter Pylori Eradication | Phase 4 | Not yet recruiting | |
| NCT06350617 | Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients | Not applicable | Recruiting | South Korea |
| NCT07641660 | Oxiris in Septic AKI | Not applicable | Not yet recruiting | South Korea |
| NCT07009418 | Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-… | Not applicable | Recruiting | South Korea |
| NCT07530913 | Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients | Not applicable | Recruiting | South Korea |
| NCT07442500 | Drug Coated Balloon vs. Drug-eluting Stent in Patients With Coronary Artery Disease | Not applicable | Not yet recruiting | South Korea |
| NCT06461793 | Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR… | Phase 2 | Recruiting | South Korea |
| NCT07783932 | Comparing the Effectiveness of Large Language Model-Based and Video-Based Refresher Education on Knowledge Re… | Not applicable | Recruiting | South Korea |
| NCT07028008 | Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Mela… | Not applicable | Not yet recruiting | |
| NCT06259162 | LAG3 Expression in Triple Negative Breast Cancer | Not applicable | Recruiting | South Korea |
| NCT05775757 | SMC Radiation Oncology Breast Cancer Cohort Study | Not applicable | Active, not recruiting | South Korea |
| NCT04591002 | Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive) | Phase 2 | Recruiting | South Korea |
| NCT06509724 | Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy | Phase 3 | Recruiting | South Korea |
| NCT07381231 | Immunotherapy With Adaptive Pulse Radiotherapy in Solid Tumors | Phase 2 | Recruiting | South Korea |
| NCT03066297 | Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer | Not applicable | Active, not recruiting | South Korea |
| NCT05796739 | Routine Versus As-Needed Stress Testing in Asymptomatic Patients With High-Risk Coronary Calcium | Not applicable | Recruiting | South Korea |
| NCT07824531 | Feasibility of Vision-Language Models for Detecting Physical Assistance as an Observable Criterion Defining G… | Not applicable | Active, not recruiting | South Korea |
| NCT07688356 | Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors | Phase 2 | Recruiting | South Korea |
| NCT07803081 | Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB Omission | Not applicable | Recruiting | South Korea |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Samsung Medical Center clinical trials: 154 open, 65 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/samsung-medical-center/, data as of 2026-10-25.